Payal Rabde, a Healthcare Industry Expert, highlights that the brain cancer diagnostics market has reached USD 4.12 billion in 2026 and is on track to reach USD 6.51 billion by 2035, advancing at a CAGR of 5.20%. Key brain cancer diagnostics market companies shaping the market include Siemens Healthineers, GE HealthCare, Philips, while major growth segments span diagnostic type, diagnostic type, tumor type, end user and region.
